Description
An FXR agonist (EC50 = 193 nM in a reporter assay); selective for FXR over the glucocorticoid, androgen, mineralocorticoid, and progesterone receptors in HEK293 cells overexpressing the human receptors (EC50s = >10 µM for all in a radioligand binding assay); increases the interaction between FXR and SRC-1 (EC50 = 121 nM in a cell-free assay); reduces plasma triglyceride and total cholesterol levels in LDL receptor-null mice (ED50s = 3.4 and 2 mg/kg, respectively); decreases plasma LDL and increases HDL levels in ZDF rats at 3, 10, and 30 mg/kg for nine days
Formal name: 6-[4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl]methoxy]-1-piperidinyl]-1-methyl-1H-indole-3-carboxylic acid
Synonyms:
Molecular weight: 540.4
CAS: 1103500-20-4
Purity: ≥95%
Formulation: A crystalline solid